Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
Jan Damoiseaux, Arad Dotan, Marvin J. Fritzler, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103012-103012
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
August Jernbom Falk, Lovisa Skoglund, Elisa Pin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry
Aaron Lerner, Carina Benzvi, Aristo Vojdani
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1937-1937
Open Access | Times Cited: 7
Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
May Y. Choi, Minoru Satoh, Marvin J. Fritzler
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 6, pp. 383-394
Open Access | Times Cited: 7
Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity
Mihailo Stjepanović, Maja Stojanović, Sanja Stanković, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
TLR7 and IgM: Dangerous Partners in Autoimmunity
Timm Amendt, Philipp Yu
Antibodies (2023) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 6
The knowns and unknowns of cardiac autoimmunity in viral myocarditis
Kiruthiga Mone, Jay Reddy
Reviews in Medical Virology (2023) Vol. 33, Iss. 6
Open Access | Times Cited: 6
Coronavirus Infection 2019 (COVID-19) and Autoimmunity
Е. Л. Насонов, Samsonov MIu, А. М. Лила
Herald of the Russian Academy of Sciences (2022) Vol. 92, Iss. 4, pp. 398-403
Open Access | Times Cited: 10
Partners in crime: Autoantibodies complicit in COVID‐19 pathogenesis
Mahdi Taghadosi, Elham Safarzadeh, Ali Asgarzadeh, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 2
Open Access | Times Cited: 10
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases
Laura Andréoli, Cecilia Beatrice Chighizola, Luca Iaccarino, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 3, pp. 103259-103259
Open Access | Times Cited: 10
Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort
Daniel Martínez-Revuelta, Juan Irure‐Ventura, Marcos López‐Hoyos, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 6, pp. 1095-1104
Open Access | Times Cited: 5
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)
Xavier Bossuyt, Jean‐Baptiste Vulsteke, Jan Van Elslande, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103288-103288
Open Access | Times Cited: 5
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
Omid Mirmosayyeb, Elham Moases Ghaffary, Mohammad Sadegh Dehghan, et al.
Journal of Central Nervous System Disease (2023) Vol. 15, pp. 117957352311678-117957352311678
Open Access | Times Cited: 5
Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients
Ignacio Piédrola, Sara Martínez, Ana Gradillas, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2
Lucy Eunju Lee, Wooyong Jeong, Yong‐Beom Park, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4152-4152
Open Access | Times Cited: 9
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study
Giuseppe Stefano Netti, Piera Soccio, Valeria Catalano, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1306-1306
Open Access | Times Cited: 1
Multiple lung abscesses and cold agglutinin syndrome following coronavirus disease 2019: a case report
Masaharu Aga, So Okubo, Toshiki Ikeda, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes
Jeroen Kerstens, Marco W.J. Schreurs, Juna M. de Vries, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 6
Closed Access | Times Cited: 1
Psychiatric Symptoms in Acute and Persisting Forms of COVID-19 Associated with Neural Autoantibodies
Niels Hansen
Antibodies (2023) Vol. 12, Iss. 3, pp. 49-49
Open Access | Times Cited: 4
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Impact of COVID-19 on thyroid gland functions with reference to Graves’ disease: A systematic review
I S Vamshidhar, Sanju Rani, M Kalpana, et al.
Journal of Family Medicine and Primary Care (2023) Vol. 12, Iss. 9, pp. 1784-1789
Open Access | Times Cited: 3
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies
Rui Sun, Yating Wang, Hassan Abolhassani
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 771-784
Closed Access | Times Cited: 2
SARS-CoV-2 and Its Bacterial Co- or Super-Infections Synergize to Trigger COVID-19 Autoimmune Cardiopathies
Robert Root‐Bernstein, Jack Huber, Alison Ziehl, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12177-12177
Open Access | Times Cited: 2
Autoimmunity on the Rise: COVID-19 as a Trigger of Autoimmunity
Arad Dotan, Yehuda Shoenfeld
Elsevier eBooks (2024), pp. 247-257
Closed Access
Review 2: "Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19"
Marvin J. Fritzler
(2024)
Open Access
Describing Elephants: An Update on the Immunopathology of Multisystem Inflammatory Syndrome in Children
Sarah van den Berg, Thomas Sun
Immunological Investigations (2024) Vol. 53, Iss. 6, pp. 962-974
Closed Access

Scroll to top